Translation News and Research

RSS

Diplomat Specialty Pharmacy to help patients obtain financial assistance to purchase life-saving drugs

Diplomat Specialty Pharmacy, the nation's largest privately held specialty pharmacy company, is on a mission to help patients obtain the financial assistance they need to purchase life-saving drugs for such illnesses as cancer, HIV/AIDS and Hepatitis C, as well as drugs for Multiple Sclerosis, kidney disease and other chronic conditions.

4 Mar 2010

P&R Dental Strategies develops and builds Rapid Review Imaging System for digitizing x-ray images

After nearly two decades building her company into the industry leader for third-party review of dental insurance claims, Dianne Rose, D.D.S., and principal of P&R Dental Strategies, Inc., was frustrated. In spite of many advances over the years in both dental x-ray technologies and the average quality of images supplied for review of dental claims, there was no consistency and, all-too-often, regardless of how up-to-date the x-ray equipment being used may have been, the images supplied were blurred and nearly useless for making accurate diagnostic determinations.

4 Mar 2010

Imaging technique combining ultrasound and microscopic bubbles help visualize tumor activity at molecular level

An imaging technique combining ultrasound and specially modified contrast agents may allow researchers to noninvasively detect cancer and show its progression, according to research published in the March issue of The Journal of Nuclear Medicine (JNM). The technique enables researchers to visualize tumor activity at the molecular level.

2 Mar 2010

Majority of prediabetic patients are not adopting preventive measures to avoid diabetes

Although it is known that diabetes can be prevented or delayed among adults at high risk through modest weight loss and increased physical activity, a study published in the April 2010 issue of the American Journal of Preventive Medicine revealed that only about half of U.S. adults with prediabetes reported that in the past year they tried to lose weight or exercise more.

2 Mar 2010

Using genetic engineering techniques in pigs, scientists create new model of diabetes

The incidence of diabetes is rising worldwide. Using genetic engineering techniques in pigs, scientists at Ludwig-Maximilians-Universität in Munich have created a new model of this metabolic disorder, which recapitulates many features of the disease, and promises to contribute significantly to improvements in diagnosis and therapy.

1 Mar 2010

NIH Director announces seven new scientific programs scheduled to begin during fiscal year 2010

Programs to create a new center for the study of stem cells and to increase capacity to deal with global health issues were among seven scientific initiatives announced today by NIH Director Francis S. Collins, M.D., Ph.D. The seven research programs are supported through the NIH Common Fund, which encourages collaborative research programs across the NIH institutes and centers, or ICs, to accomplish work that no single IC could do alone.

26 Feb 2010

AcademyHealth launches Minority Scholars Program to encourage students in health services research

AcademyHealth announced today the launch of a new initiative to encourage students and fellows from minority populations underrepresented in the field of health services research (HSR) to explore opportunities in the field, particularly in regard to disparities research.

26 Feb 2010

Bruker fourth-quarter GAAP revenue up 16%

Bruker Corporation today reported financial results for the fourth quarter and year ended December 31, 2009.

25 Feb 2010

"Hope – It's In Our Genes" rare disease campaign slogan translated into multiple international languages and Braille

The Global Genes Project (www.globalgenesproject.org), today announced that its rare disease campaign slogan, "Hope – It's In Our Genes™," has been translated into multiple international languages and Braille by rare disease patient advocates and supporters from around the world. The translation of this slogan unifies the rare disease community and global network under one banner.

25 Feb 2010

Mylan reports total revenues of $1.35 billion for fourth-quarter 2009

Mylan Inc. today announced its financial results for the three and twelve months ended December 31, 2009.

25 Feb 2010

LifeSciences British Columbia, UBC to host global summit on HIV/AIDS

LifeSciences British Columbia, the BC Centre of Excellence in HIV/AIDS, and the University of British Columbia will host a global summit on HIV/AIDS on Feb. 26th, 2010, against the backdrop of the 2010 Olympic Games.

24 Feb 2010

NIH awards Sanaria Phase II SBIR grant to develop genetically attenuated, whole parasite malaria vaccine

Sanaria Inc. has received additional support from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health in the form of a Phase II Small Business Innovation Research (SBIR) Grant. The three-year award totaling approximately $3 million will support collaborative research by investigators at Sanaria and Columbia University.

23 Feb 2010

Gene study provides new clues to fight infections

Investigators at The Methodist Hospital Research Institute in Houston examined for the first time the long-term response to strep throat on a genome-wide level, shedding light on how group A streptococcus interacts with the patient's immune system and attempts to circumvent it.

23 Feb 2010

CDA Foundation selects five organizations to improve oral health care for state's most vulnerable residents

Continuing its efforts to improve oral health care for the state's most vulnerable residents, the California Dental Association Foundation today announced the latest organizations selected for support through its popular grant program. This year, the philanthropic effort is supported in part by Olympic Dental & Medical Devices.

20 Feb 2010

UBC researcher finds improved uptake of highly active antiretroviral therapy

A comprehensive population-based study, conducted by the BC Centre for Excellence in HIV/AIDS (BC-CfE) and presented at the 17th Conference on Retroviruses and Opportunistic Infections in San Francisco, shows that expanded highly active antiretroviral therapy (HAART) coverage was associated with a 50% decrease in new yearly HIV infections among injection drug users.

19 Feb 2010

RainDance Technologies enters into strategic agreement with Applied Biosystems

RainDance Technologies, Inc., a leading provider of innovative microdroplet-based solutions for human health and disease research, and Applied Biosystems, part of Life Technologies Corporation, announced today they have entered into a strategic agreement to co-market the first solution that combines microdroplet PCR-based sequence enrichment with next-generation sequencing.

19 Feb 2010

West Pharmaceutical Services reports 19.9% growth in consolidated fourth-quarter sales

West Pharmaceutical Services, Inc. today announced its results for the fourth quarter and full year of 2009.

18 Feb 2010

NPG becomes official media partner to the 2010 WIN Symposium

Nature Publishing Group (NPG) is the official media partner to the 2010 WIN (Worldwide Innovative Networking) Symposium, it was announced today. The second annual WIN Symposium, which will be held in the Palais des Congrès, Paris, 7–9 July 2010, will bring together hundreds of oncology researchers from around the world to discuss how best to tailor therapies for patients with cancer.

18 Feb 2010

Keystone Health increases access to healthcare with ARRA grants: Secretary of Health commends

Secretary of Health Everette James commended Keystone Health for increasing access to healthcare with grants from the American Recovery and Reinvestment Act during a groundbreaking ceremony today at the facility's main campus in Chambersburg.

18 Feb 2010

Teva Pharmaceutical Industries announces fourth-quarter and full-year 2009 financial results

Teva Pharmaceutical Industries Ltd. today reported record results for the quarter and year ended December 31, 2009.

16 Feb 2010

Translation News and Research

Diplomat Specialty Pharmacy to help patients obtain financial assistance to purchase life-saving drugs

P&R Dental Strategies develops and builds Rapid Review Imaging System for digitizing x-ray images

Imaging technique combining ultrasound and microscopic bubbles help visualize tumor activity at molecular level

Majority of prediabetic patients are not adopting preventive measures to avoid diabetes

Using genetic engineering techniques in pigs, scientists create new model of diabetes

NIH Director announces seven new scientific programs scheduled to begin during fiscal year 2010

AcademyHealth launches Minority Scholars Program to encourage students in health services research

Bruker fourth-quarter GAAP revenue up 16%

"Hope – It's In Our Genes" rare disease campaign slogan translated into multiple international languages and Braille

Mylan reports total revenues of $1.35 billion for fourth-quarter 2009

LifeSciences British Columbia, UBC to host global summit on HIV/AIDS

NIH awards Sanaria Phase II SBIR grant to develop genetically attenuated, whole parasite malaria vaccine

Gene study provides new clues to fight infections

CDA Foundation selects five organizations to improve oral health care for state's most vulnerable residents

UBC researcher finds improved uptake of highly active antiretroviral therapy

RainDance Technologies enters into strategic agreement with Applied Biosystems

West Pharmaceutical Services reports 19.9% growth in consolidated fourth-quarter sales

NPG becomes official media partner to the 2010 WIN Symposium

Keystone Health increases access to healthcare with ARRA grants: Secretary of Health commends

Teva Pharmaceutical Industries announces fourth-quarter and full-year 2009 financial results

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News